Author

Justine L. Wilson-Miller

Observed name: Justine Wilson-Miller

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5115022701

Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization

2025 · Jenna R. Puttkammer, Jason N. Barreto, et al. · JCO Oncology Practice · 6

Real-World Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Treatment Delivery, Immune Reconstitution, and Cardiac Monitoring During High-Dose IL-2

2026 · Mohamed A. Aboelatta, Jabra Zarka, et al. · Current Oncology

Influence of peri-dose high-sensitivity troponin on clinically significant cardiac events and IL-2 interruption during post-TIL high-dose IL-2 therapy.

2026 · Jabra Zarka, Mohamed A. Aboelatta, et al. · Journal of Clinical Oncology

235: Icu Management of Toxicities Associated With Tumor-infiltrating Lymphocyte Therapy and Interleukin-2

2026 · Heather May, Justine Wilson-Miller, et al. · Critical Care Medicine

Impact of a Multidisciplinary SAE Oversight Committee on CAR-T Toxicity Management: Clinical Outcomes and Provider Perceptions

2026 · Melinda Tan, Malvika Gupta, et al. · Transplantation and Cellular Therapy

Prognostic value of immunoparesis, lymphopenia, high serum ferritin, and suppression of the non-involved serum free light chains (niFLC) in relapsed and refractory multiple myeloma patients (RRMM) receiving bispecific antibodies

2025 · Valentina Cardenas Castro, Kevin Shim, et al. · Blood

Erratum: Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization

2025 · Jenna R. Puttkammer, Jason N. Barreto, et al. · JCO Oncology Practice

Outpatient Management of Bispecific Related Toxicities: An Observational Study of Safety Outcomes and Resource Utilization

2024 · Tyler B. Sandahl, Jenna Puttkammer, et al. · Blood

Works count: 8

Citation count: 6

H-index: 1

I10-index: